Medindia

X

Gene That Mediates Cisplatin Resistance in Ovarian Cancer Identified

by Sheela Philomena on  April 17, 2013 at 1:17 PM Genetics & Stem Cells News   - G J E 4
In ovarian cancer, the gene that mediates cisplatin resistance has been discovered by scientists. Mechanisms of resistance typically include reduced platinum uptake and increased platinum export.
 Gene That Mediates Cisplatin Resistance in Ovarian Cancer Identified
Gene That Mediates Cisplatin Resistance in Ovarian Cancer Identified
Advertisement

In this issue of the Journal of Clinical Investigation, Anil Sood and colleagues at M.D. Anderson Cancer Center identified a cellular membrane protein, ATP11B, that mediates cisplatin resistance in ovarian cancer cells. They found that ATP11B expression was correlated with higher tumor grade in human ovarian cancer samples and with cisplatin-resistance in human ovarian cancer cell lines. Further, loss of ATP11B restored the sensitivity of ovarian cancer cell lines to cisplatin and reduced ovarian tumor growth in mice. These findings suggest that ATP11B could serve as a therapeutic target to overcome cisplatin resistance.

Advertisement
Source: Eurekalert
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All